Issue 9/2017
Content (23 Articles)
FDG-PET/CT for systemic staging of patients with newly diagnosed breast cancer
David Groheux
18F–FDG-PET/CT for systemic staging of patients with newly diagnosed ER-positive and HER2-positive breast cancer
Gary A. Ulaner, Raychel Castillo, Jonathan Wills, Mithat Gönen, Debra A. Goldman
Comparison of FDG-PET/CT and contrast-enhanced CT for monitoring therapy response in patients with metastatic breast cancer
Christopher C. Riedl, Katja Pinker, Gary A. Ulaner, Leonard T. Ong, Pascal Baltzer, Maxine S. Jochelson, Heather L. McArthur, Mithat Gönen, Maura Dickler, Wolfgang A. Weber
Strong association of epidermal growth factor receptor status with breast cancer FDG uptake
Joohee Lee, Eun Jeong Lee, Seung Hwan Moon, Seokhwi Kim, Seung Hyup Hyun, Young Seok Cho, Joon Young Choi, Byung-Tae Kim, Kyung-Han Lee
Overall survival and response pattern of castration-resistant metastatic prostate cancer to multiple cycles of radioligand therapy using [177Lu]Lu-PSMA-617
Hojjat Ahmadzadehfar, Simone Wegen, Anna Yordanova, Rolf Fimmers, Stefan Kürpig, Elisabeth Eppard, Xiao Wei, Carl Schlenkhoff, Stefan Hauser, Markus Essler
Comparison of PSMA-HBED and PSMA-I&T as diagnostic agents in prostate carcinoma
Michael McCarthy, Tiffany Langton, Divesh Kumar, Andrew Campbell
Diagnosis of recurrent prostate cancer with PET/CT imaging using the gastrin-releasing peptide receptor antagonist 68Ga-RM2: Preliminary results in patients with negative or inconclusive [18F]Fluoroethylcholine-PET/CT
Gesche Wieser, Ilinca Popp, H. Christian Rischke, Vanessa Drendel, Anca-Ligia Grosu, Mark Bartholomä, Wolfgang A. Weber, Rosalba Mansi, Ulrich Wetterauer, Wolfgang Schultze-Seemann, Philipp T. Meyer, Cordula Annette Jilg
The impact of repeated cycles of radioligand therapy using [177Lu]Lu-PSMA-617 on renal function in patients with hormone refractory metastatic prostate cancer
Anna Yordanova, Anja Becker, Elisabeth Eppard, Stefan Kürpig, Christian Fisang, Georg Feldmann, Markus Essler, Hojjat Ahmadzadehfar
Individualised 177Lu-DOTATATE treatment of neuroendocrine tumours based on kidney dosimetry
Anna Sundlöv, Katarina Sjögreen-Gleisner, Johanna Svensson, Michael Ljungberg, Tomas Olsson, Peter Bernhardt, Jan Tennvall
Personalized 177Lu-octreotate peptide receptor radionuclide therapy of neuroendocrine tumours: a simulation study
Michela Del Prete, François-Alexandre Buteau, Jean-Mathieu Beauregard
Microsurgery guided by sequential preoperative lymphography using 68Ga-NEB PET and MRI in patients with lower-limb lymphedema
Xiao Long, Jingjing Zhang, Daming Zhang, Chao Gao, Chongwei Chi, Elan Yang, Huadan Xue, Lixin Lang, Gang Niu, Zhaohui Zhu, Fang Li, Xiaoyuan Chen
Sentinel lymph node mapping using SPECT/CT and gamma probe in endometrial cancer: an analysis of parameters affecting detection rate
Samine Sahbai, Florin-Andrei Taran, Annette Staebler, Diethelm Wallwiener, Christian la Fougère, Sara Brucker, Helmut Dittmann
Inter-heterogeneity and intra-heterogeneity of αvβ3 in non-small cell lung cancer and small cell lung cancer patients as revealed by 68Ga-RGD2 PET imaging
Fei Kang, Zhe Wang, Guoquan Li, Shengjun Wang, Daliang Liu, Mingru Zhang, Mingxuan Zhao, Weidong Yang, Jing Wang
Quantification of temporal changes in calcium score in active atherosclerotic plaque in major vessels by 18F-sodium fluoride PET/CT
Yoshinobu Ishiwata, Tomohiro Kaneta, Shintaro Nawata, Ayako Hino-Shishikura, Keisuke Yoshida, Tomio Inoue
Single-scan rest/stress imaging: validation in a porcine model with 18F-Flurpiridaz
Nicolas J. Guehl, Marc D. Normandin, Dustin W. Wooten, Guy Rozen, Arkadiusk Sitek, Jeremy Ruskin, Timothy M. Shoup, Leon M. Ptaszek, Georges El Fakhri, Nathaniel M. Alpert
Long-term prognostic implications of myocardial perfusion imaging in octogenarians: an all-comer, cohort study
Athanasios Katsikis, Athanasios Theodorakos, Vassiliki Manira, Spyridon Papaioannou, Genovefa Kolovou, Vassilios Voudris, Maria Koutelou
Highlights lecture EANM 2016: “Embracing molecular imaging and multi-modal imaging: a smart move for nuclear medicine towards personalized medicine”
Eric O. Aboagye, Françoise Kraeber-Bodéré
18F-fluorodeoxyglucose positron emission tomography in the diagnosis of malignancy in patients with paraneoplastic neurological syndrome: a systematic review and meta-analysis
Ana María García Vicente, Roberto C. Delgado-Bolton, Mariano Amo-Salas, Jesús López-Fidalgo, Ana Paula Caresia Aróztegui, José Ramón García Garzón, Javier Orcajo Rincón, María José García Velloso, María de Arcocha Torres, Soledad Alvárez Ruíz, Ana María García Vicente, Roberto C. Delgado-Bolton, Ana Paula Caresia Aróztegui, José Ramón García Garzón, Javier Orcajo Rincón, María José García Velloso, María de Arcocha Torres, Soledad Alvárez Ruíz
Guideline for PET/CT imaging of neuroendocrine neoplasms with 68Ga-DOTA-conjugated somatostatin receptor targeting peptides and 18F–DOPA
Murat Fani Bozkurt, Irene Virgolini, Sona Balogova, Mohsen Beheshti, Domenico Rubello, Clemens Decristoforo, Valentina Ambrosini, Andreas Kjaer, Roberto Delgado-Bolton, Jolanta Kunikowska, Wim J. G. Oyen, Arturo Chiti, Francesco Giammarile, Stefano Fanti
FDG PET for therapy monitoring in Hodgkin’s and non-Hodgkin’s lymphomas: qPET versus rPET
Eric Laffon, Roger Marthan
An insight into the EANM technologist committee benchmark document on nuclear medicine technologists’ competencies
Pedro Fragoso Costa, Andrea Santos, Giorgio Testanera
Fibrous dysplasia mimicking bone metastasis on 68GA-PSMA PET/MRI
Liesbeth De Coster, Raf Sciot, Wouter Everaerts, Olivier Gheysens, Raf Verscuren, Christophe M. Deroose, Steven Pans, Koen Van Laere, Karolien E. Goffin
Diffuse 18F-FDG uptake throughout the spinal cord in the acute phase of Neuromyelitis Optica Spectrum disorder
Akira Higashiyama, Tsuyoshi Komori, Yuki Inada, Mitsuo Nishizawa, Hideto Nakajima, Yoshifumi Narumi